accession	library_ID	title	library_strategy	library_source	library_selection	library_layout	platform	instrument_model	design_description	filetype	filename
SAMN34331669	E177_14_10_1_2_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EPZ-6438 in position C02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_26_C2_AGCAGGAA_10_1_2_R1.fq.gz
SAMN34331670	E177_14_10_1_2_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MM-102 in position C03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_27_C3_AGTCACTA_10_1_2_R1.fq.gz
SAMN34331671	E177_14_10_1_2_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM OTX015 in position C04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_28_C4_ATCCTGTA_10_1_2_R1.fq.gz
SAMN34331672	E177_14_10_1_2_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BIX 01294 in position C05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_29_C5_ATTGAGGA_10_1_2_R1.fq.gz
SAMN34331673	E177_14_10_1_2_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Panobinostat (LBH589) in position C06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_30_C6_CAACCACA_10_1_2_R1.fq.gz
SAMN34331674	E177_14_10_1_2_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EPZ5676 in position C07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_31_C7_CAAGACTA_10_1_2_R1.fq.gz
SAMN34331675	E177_14_10_1_2_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Splitomicin in position C08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_32_C8_CAATGGAA_10_1_2_R1.fq.gz
SAMN34331676	E177_14_10_1_2_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Valproic acid in position C09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_33_C9_CACTTCGA_10_1_2_R1.fq.gz
SAMN34331677	E177_14_10_1_2_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MC-1293 in position C10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_34_C10_CAGCGTTA_10_1_2_R1.fq.gz
SAMN34331678	E177_14_10_1_2_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-278 in position C11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_35_C11_CATACCAA_10_1_2_R1.fq.gz
SAMN34331267	E177_14_10_1_2_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_36_C12_CCAGTTCA_10_1_2_R1.fq.gz
SAMN34331278	E177_14_10_1_2_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_37_D1_CCGAAGTA_10_1_2_R1.fq.gz
SAMN34331679	E177_14_10_1_2_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM C646 in position D02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_38_D2_CCGTGAGA_10_1_2_R1.fq.gz
SAMN34331680	E177_14_10_1_2_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGI-1027 in position D03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_39_D3_CCTCCTGA_10_1_2_R1.fq.gz
SAMN34331681	E177_14_10_1_2_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM UNC669 in position D04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_40_D4_CGAACTTA_10_1_2_R1.fq.gz
SAMN34331682	E177_14_10_1_2_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM UPF 1069 in position D05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_41_D5_CGACTGGA_10_1_2_R1.fq.gz
SAMN34331683	E177_14_10_1_2_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Trichostatin A (TSA) in position D06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_42_D6_CGCATACA_10_1_2_R1.fq.gz
SAMN34331684	E177_14_10_1_2_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM GSK J4 HCl in position D07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_43_D7_CTCAATGA_10_1_2_R1.fq.gz
SAMN34331685	E177_14_10_1_2_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-210 in position D08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_44_D8_CTGAGCCA_10_1_2_R1.fq.gz
SAMN34331686	E177_14_10_1_2_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Nicotinamide in position D09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_45_D9_CTGGCATA_10_1_2_R1.fq.gz
SAMN34331687	E177_14_10_1_2_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Anacardic acid in position D10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_46_D10_GAATCTGA_10_1_2_R1.fq.gz
SAMN34331688	E177_14_10_1_2_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM NCH-51 in position D11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_47_D11_GACTAGTA_10_1_2_R1.fq.gz
SAMN34331278	E177_14_10_1_2_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_48_D12_GAGCTGAA_10_1_2_R1.fq.gz
SAMN34331245	E177_14_10_1_2_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_49_E1_GATAGACA_10_1_2_R1.fq.gz
SAMN34331689	E177_14_10_1_2_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM I-BET-762 in position E02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_50_E2_GCCACATA_10_1_2_R1.fq.gz
SAMN34331690	E177_14_10_1_2_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RG2833 (RGFP109) in position E03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_51_E3_GCGAGTAA_10_1_2_R1.fq.gz
SAMN34331691	E177_14_10_1_2_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ME0328 in position E04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_52_E4_GCTAACGA_10_1_2_R1.fq.gz
SAMN34331692	E177_14_10_1_2_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Scriptaid in position E05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_53_E5_GCTCGGTA_10_1_2_R1.fq.gz
SAMN34331693	E177_14_10_1_2_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Vorinostat (SAHA, MK0683) in position E06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_54_E6_GGAGAACA_10_1_2_R1.fq.gz
SAMN34331694	E177_14_10_1_2_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGC 0946 in position E07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_55_E7_GGTGCGAA_10_1_2_R1.fq.gz
SAMN34331695	E177_14_10_1_2_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Apicidin in position E08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_56_E8_GTACGCAA_10_1_2_R1.fq.gz
SAMN34331696	E177_14_10_1_2_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-266 in position E09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_57_E9_GTCGTAGA_10_1_2_R1.fq.gz
SAMN34331697	E177_14_10_1_2_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM B2 in position E10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_58_E10_GTCTGTCA_10_1_2_R1.fq.gz
SAMN34331698	E177_14_10_1_2_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM NSC-3852 in position E11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_59_E11_GTGTTCTA_10_1_2_R1.fq.gz
SAMN34331245	E177_14_10_1_2_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_60_E12_TAGGATGA_10_1_2_R1.fq.gz
SAMN34331256	E177_14_10_1_2_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_61_F1_TATCAGCA_10_1_2_R1.fq.gz
SAMN34331699	E177_14_10_1_2_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RGFP966 in position F02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_62_F2_TCCGTCTA_10_1_2_R1.fq.gz
SAMN34331700	E177_14_10_1_2_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RVX-208 in position F03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_63_F3_TCTTCACA_10_1_2_R1.fq.gz
SAMN34331701	E177_14_10_1_2_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Nexturastat A in position F04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_64_F4_TGAAGAGA_10_1_2_R1.fq.gz
SAMN34331702	E177_14_10_1_2_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tubastatin A in position F05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_65_F5_TGGAACAA_10_1_2_R1.fq.gz
SAMN34331703	E177_14_10_1_2_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM VX-680 (Tozasertib, MK-0457) in position F06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_66_F6_TGGCTTCA_10_1_2_R1.fq.gz
SAMN34331704	E177_14_10_1_2_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM UNC1215 in position F07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_67_F7_TGGTGGTA_10_1_2_R1.fq.gz
SAMN34331705	E177_14_10_1_2_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Suberoyl bis-hydroxamic acid in position F08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_68_F8_TTCACGCA_10_1_2_R1.fq.gz
SAMN34331706	E177_14_10_1_2_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Piceatannol in position F09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_69_F9_AACTCACC_10_1_2_R1.fq.gz
SAMN34331707	E177_14_10_1_2_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BIX-01294·3HCl in position F10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_70_F10_AAGAGATC_10_1_2_R1.fq.gz
SAMN34331708	E177_14_10_1_2_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Aminoresveratrol sulfate in position F11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_71_F11_AAGGACAC_10_1_2_R1.fq.gz
SAMN34331256	E177_14_10_1_2_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_72_F12_AATCCGTC_10_1_2_R1.fq.gz
SAMN34331267	E177_14_10_1_2_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_73_G1_AATGTTGC_10_1_2_R1.fq.gz
SAMN34331709	E177_14_10_1_2_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Bromosporine in position G02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_74_G2_ACACGACC_10_1_2_R1.fq.gz
SAMN34331710	E177_14_10_1_2_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PJ34 HCl in position G03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_75_G3_ACAGATTC_10_1_2_R1.fq.gz
SAMN34331711	E177_14_10_1_2_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Filgotinib (GLPG0634) in position G04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_76_G4_AGATGTAC_10_1_2_R1.fq.gz
SAMN34331712	E177_14_10_1_2_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Lomeguatrib in position G05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_77_G5_AGCACCTC_10_1_2_R1.fq.gz
SAMN34331713	E177_14_10_1_2_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Entinostat (MS-275) in position G06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_78_G6_AGCCATGC_10_1_2_R1.fq.gz
SAMN34331714	E177_14_10_1_2_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZD1208 in position G07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_79_G7_AGGCTAAC_10_1_2_R1.fq.gz
SAMN34331715	E177_14_10_1_2_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Nullscript in position G08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_80_G8_ATAGCGAC_10_1_2_R1.fq.gz
SAMN34331716	E177_14_10_1_2_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Fluoro-SAHA in position G09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_81_G9_ATCATTCC_10_1_2_R1.fq.gz
SAMN34331717	E177_14_10_1_2_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Butyrolactone 3 in position G10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_82_G10_ATTGGCTC_10_1_2_R1.fq.gz
SAMN34331718	E177_14_10_1_2_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-281 in position G11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_83_G11_CAAGGAGC_10_1_2_R1.fq.gz
SAMN34331267	E177_14_10_1_2_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_84_G12_CACCTTAC_10_1_2_R1.fq.gz
SAMN34331278	E177_14_10_1_2_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_85_H1_CCATCCTC_10_1_2_R1.fq.gz
SAMN34331719	E177_14_10_1_2_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM IOX1 in position H02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_86_H2_CCGACAAC_10_1_2_R1.fq.gz
SAMN34331720	E177_14_10_1_2_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CPI-203 in position H03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_87_H3_CCTAATCC_10_1_2_R1.fq.gz
SAMN34331721	E177_14_10_1_2_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Rocilinostat (ACY-1215) in position H04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_88_H4_CCTCTATC_10_1_2_R1.fq.gz
SAMN34331722	E177_14_10_1_2_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Pacritinib (SB1518) in position H05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_89_H5_CGACACAC_10_1_2_R1.fq.gz
SAMN34331723	E177_14_10_1_2_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Olaparib (AZD2281, Ku-0059436) in position H06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_90_H6_CGGATTGC_10_1_2_R1.fq.gz
SAMN34331724	E177_14_10_1_2_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM (+)-JQ1 in position H07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_91_H7_CTAAGGTC_10_1_2_R1.fq.gz
SAMN34331725	E177_14_10_1_2_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Isonicotinamide in position H08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_92_H8_GAACAGGC_10_1_2_R1.fq.gz
SAMN34331726	E177_14_10_1_2_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Valproic acid hydroxamate in position H09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_93_H9_GACAGTGC_10_1_2_R1.fq.gz
SAMN34331727	E177_14_10_1_2_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CTPB in position H10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_94_H10_GAGTTAGC_10_1_2_R1.fq.gz
SAMN34331728	E177_14_10_1_2_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Triacetylresveratrol in position H11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_95_H11_GATGAATC_10_1_2_R1.fq.gz
SAMN34331278	E177_14_10_1_2_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_96_H12_GCCAAGAC_10_1_2_R1.fq.gz
SAMN34331245	E177_15_10_2_1_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_1_A1_ACAAGCTA_10_2_1_R1.fq.gz
SAMN34331569	E177_15_10_2_1_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Belinostat (PXD101) in position A02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_2_A2_AAACATCG_10_2_1_R1.fq.gz
SAMN34331570	E177_15_10_2_1_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Danusertib (PHA-739358) in position A03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_3_A3_ACATTGGC_10_2_1_R1.fq.gz
SAMN34331571	E177_15_10_2_1_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SNS-314 Mesylate in position A04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_4_A4_ACCACTGT_10_2_1_R1.fq.gz
SAMN34331572	E177_15_10_2_1_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM JNJ-7706621 in position A05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_5_A5_AACGTGAT_10_2_1_R1.fq.gz
SAMN34331573	E177_15_10_2_1_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CCT129202 in position A06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_6_A6_CGCTGATC_10_2_1_R1.fq.gz
SAMN34331574	E177_15_10_2_1_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AG-14361 in position A07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_7_A7_CAGATCTG_10_2_1_R1.fq.gz
SAMN34331575	E177_15_10_2_1_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tubastatin A HCl in position A08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_8_A8_ATGCCTAA_10_2_1_R1.fq.gz
SAMN34331576	E177_15_10_2_1_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CUDC-907 in position A09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_9_A9_CTGTAGCC_10_2_1_R1.fq.gz
SAMN34331577	E177_15_10_2_1_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CI994 (Tacedinaline) in position A10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_10_A10_AGTACAAG_10_2_1_R1.fq.gz
SAMN34331578	E177_15_10_2_1_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Entacapone in position A11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_11_A11_CATCAAGT_10_2_1_R1.fq.gz
SAMN34331245	E177_15_10_2_1_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_12_A12_AGTGGTCA_10_2_1_R1.fq.gz
SAMN34331256	E177_15_10_2_1_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_13_B1_AACAACCA_10_2_1_R1.fq.gz
SAMN34331579	E177_15_10_2_1_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Iniparib (BSI-201) in position B02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_14_B2_AACCGAGA_10_2_1_R1.fq.gz
SAMN34331580	E177_15_10_2_1_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Mocetinostat (MGCD0103) in position B03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_15_B3_AACGCTTA_10_2_1_R1.fq.gz
SAMN34331581	E177_15_10_2_1_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Valproic acid sodium salt (Sodium valproate) in position B04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_16_B4_AAGACGGA_10_2_1_R1.fq.gz
SAMN34331582	E177_15_10_2_1_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Ruxolitinib (INCB018424) in position B05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_17_B5_AAGGTACA_10_2_1_R1.fq.gz
SAMN34331583	E177_15_10_2_1_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Hesperadin in position B06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_18_B6_ACACAGAA_10_2_1_R1.fq.gz
SAMN34331584	E177_15_10_2_1_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM LY2784544 in position B07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_19_B7_ACAGCAGA_10_2_1_R1.fq.gz
SAMN34331585	E177_15_10_2_1_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM NVP-BSK805 2HCl in position B08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_20_B8_ACCTCCAA_10_2_1_R1.fq.gz
SAMN34331586	E177_15_10_2_1_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MK-5108 (VX-689) in position B09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_21_B9_ACGCTCGA_10_2_1_R1.fq.gz
SAMN34331587	E177_15_10_2_1_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RG108 in position B10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_22_B10_ACGTATCA_10_2_1_R1.fq.gz
SAMN34331588	E177_15_10_2_1_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Sodium Phenylbutyrate in position B11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_23_B11_ACTATGCA_10_2_1_R1.fq.gz
SAMN34331256	E177_15_10_2_1_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_24_B12_AGAGTCAA_10_2_1_R1.fq.gz
SAMN34331267	E177_15_10_2_1_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_25_C1_AGATCGCA_10_2_1_R1.fq.gz
SAMN34331589	E177_15_10_2_1_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PCI-24781 (Abexinostat) in position C02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_26_C2_AGCAGGAA_10_2_1_R1.fq.gz
SAMN34331590	E177_15_10_2_1_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SRT1720 in position C03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_27_C3_AGTCACTA_10_2_1_R1.fq.gz
SAMN34331591	E177_15_10_2_1_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CYC116 in position C04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_28_C4_ATCCTGTA_10_2_1_R1.fq.gz
SAMN34331592	E177_15_10_2_1_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Resveratrol in position C05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_29_C5_ATTGAGGA_10_2_1_R1.fq.gz
SAMN34331593	E177_15_10_2_1_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EX 527 (Selisistat) in position C06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_30_C6_CAACCACA_10_2_1_R1.fq.gz
SAMN34331594	E177_15_10_2_1_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGI-1776 free base in position C07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_31_C7_CAAGACTA_10_2_1_R1.fq.gz
SAMN34331595	E177_15_10_2_1_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TG101209 in position C08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_32_C8_CAATGGAA_10_2_1_R1.fq.gz
SAMN34331596	E177_15_10_2_1_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM M344 in position C09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_33_C9_CACTTCGA_10_2_1_R1.fq.gz
SAMN34331597	E177_15_10_2_1_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Baricitinib (LY3009104, INCB028050) in position C10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_34_C10_CAGCGTTA_10_2_1_R1.fq.gz
SAMN34331598	E177_15_10_2_1_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tranylcypromine (2-PCPA) HCl in position C11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_35_C11_CATACCAA_10_2_1_R1.fq.gz
SAMN34331267	E177_15_10_2_1_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_36_C12_CCAGTTCA_10_2_1_R1.fq.gz
SAMN34331278	E177_15_10_2_1_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_37_D1_CCGAAGTA_10_2_1_R1.fq.gz
SAMN34331599	E177_15_10_2_1_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM LAQ824 (Dacinostat) in position D02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_38_D2_CCGTGAGA_10_2_1_R1.fq.gz
SAMN34331600	E177_15_10_2_1_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM INO-1001 in position D03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_39_D3_CCTCCTGA_10_2_1_R1.fq.gz
SAMN34331601	E177_15_10_2_1_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ENMD-2076 in position D04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_40_D4_CGAACTTA_10_2_1_R1.fq.gz
SAMN34331602	E177_15_10_2_1_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Droxinostat in position D05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_41_D5_CGACTGGA_10_2_1_R1.fq.gz
SAMN34331603	E177_15_10_2_1_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Azacitidine in position D06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_42_D6_CGCATACA_10_2_1_R1.fq.gz
SAMN34331604	E177_15_10_2_1_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZ 960 in position D07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_43_D7_CTCAATGA_10_2_1_R1.fq.gz
SAMN34331605	E177_15_10_2_1_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Resminostat in position D08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_44_D8_CTGAGCCA_10_2_1_R1.fq.gz
SAMN34331606	E177_15_10_2_1_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM I-BET151 (GSK1210151A) in position D09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_45_D9_CTGGCATA_10_2_1_R1.fq.gz
SAMN34331607	E177_15_10_2_1_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM WHI-P154 in position D10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_46_D10_GAATCTGA_10_2_1_R1.fq.gz
SAMN34331608	E177_15_10_2_1_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 3-Aminobenzamide in position D11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_47_D11_GACTAGTA_10_2_1_R1.fq.gz
SAMN34331278	E177_15_10_2_1_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_48_D12_GAGCTGAA_10_2_1_R1.fq.gz
SAMN34331245	E177_15_10_2_1_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_49_E1_GATAGACA_10_2_1_R1.fq.gz
SAMN34331609	E177_15_10_2_1_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Quisinostat (JNJ-26481585) in position E02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_50_E2_GCCACATA_10_2_1_R1.fq.gz
SAMN34331610	E177_15_10_2_1_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Alisertib (MLN8237) in position E03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_51_E3_GCGAGTAA_10_2_1_R1.fq.gz
SAMN34331611	E177_15_10_2_1_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CUDC-101 in position E04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_52_E4_GCTAACGA_10_2_1_R1.fq.gz
SAMN34331612	E177_15_10_2_1_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Aurora A Inhibitor I in position E05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_53_E5_GCTCGGTA_10_2_1_R1.fq.gz
SAMN34331613	E177_15_10_2_1_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PCI-34051 in position E06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_54_E6_GGAGAACA_10_2_1_R1.fq.gz
SAMN34331614	E177_15_10_2_1_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CYT387 in position E07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_55_E7_GGTGCGAA_10_2_1_R1.fq.gz
SAMN34331615	E177_15_10_2_1_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TAK-901 in position E08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_56_E8_GTACGCAA_10_2_1_R1.fq.gz
SAMN34331616	E177_15_10_2_1_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tofacitinib (CP-690550,Tasocitinib) in position E09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_57_E9_GTCGTAGA_10_2_1_R1.fq.gz
SAMN34331617	E177_15_10_2_1_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PJ34 in position E10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_58_E10_GTCTGTCA_10_2_1_R1.fq.gz
SAMN34331618	E177_15_10_2_1_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Procainamide HCl in position E11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_59_E11_GTGTTCTA_10_2_1_R1.fq.gz
SAMN34331245	E177_15_10_2_1_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_60_E12_TAGGATGA_10_2_1_R1.fq.gz
SAMN34331256	E177_15_10_2_1_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_61_F1_TATCAGCA_10_2_1_R1.fq.gz
SAMN34331619	E177_15_10_2_1_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Rucaparib (AG-014699,PF-01367338) in position F02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_62_F2_TCCGTCTA_10_2_1_R1.fq.gz
SAMN34331620	E177_15_10_2_1_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AT9283 in position F03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_63_F3_TCTTCACA_10_2_1_R1.fq.gz
SAMN34331621	E177_15_10_2_1_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Decitabine in position F04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_64_F4_TGAAGAGA_10_2_1_R1.fq.gz
SAMN34331622	E177_15_10_2_1_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PHA-680632 in position F05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_65_F5_TGGAACAA_10_2_1_R1.fq.gz
SAMN34331623	E177_15_10_2_1_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM KW-2449 in position F06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_66_F6_TGGCTTCA_10_2_1_R1.fq.gz
SAMN34331624	E177_15_10_2_1_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tubacin in position F07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_67_F7_TGGTGGTA_10_2_1_R1.fq.gz
SAMN34331625	E177_15_10_2_1_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AMG-900 in position F08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_68_F8_TTCACGCA_10_2_1_R1.fq.gz
SAMN34331626	E177_15_10_2_1_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM WP1066 in position F09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_69_F9_AACTCACC_10_2_1_R1.fq.gz
SAMN34331627	E177_15_10_2_1_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM S-Ruxolitinib (INCB018424) in position F10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_70_F10_AAGAGATC_10_2_1_R1.fq.gz
SAMN34331628	E177_15_10_2_1_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tofacitinib (CP-690550) Citrate in position F11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_71_F11_AAGGACAC_10_2_1_R1.fq.gz
SAMN34331256	E177_15_10_2_1_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_72_F12_AATCCGTC_10_2_1_R1.fq.gz
SAMN34331267	E177_15_10_2_1_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_73_G1_AATGTTGC_10_2_1_R1.fq.gz
SAMN34331629	E177_15_10_2_1_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MLN8054 in position G02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_74_G2_ACACGACC_10_2_1_R1.fq.gz
SAMN34331630	E177_15_10_2_1_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AG-490 (Tyrphostin B42) in position G03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_75_G3_ACAGATTC_10_2_1_R1.fq.gz
SAMN34331631	E177_15_10_2_1_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PFI-1 (PF-6405761) in position G04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_76_G4_AGATGTAC_10_2_1_R1.fq.gz
SAMN34331632	E177_15_10_2_1_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MC1568 in position G05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_77_G5_AGCACCTC_10_2_1_R1.fq.gz
SAMN34331633	E177_15_10_2_1_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZD1480 in position G06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_78_G6_AGCCATGC_10_2_1_R1.fq.gz
SAMN34331634	E177_15_10_2_1_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AR-42 in position G07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_79_G7_AGGCTAAC_10_2_1_R1.fq.gz
SAMN34331635	E177_15_10_2_1_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TG101348 (SAR302503) in position G08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_80_G8_ATAGCGAC_10_2_1_R1.fq.gz
SAMN34331636	E177_15_10_2_1_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Sirtinol in position G09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_81_G9_ATCATTCC_10_2_1_R1.fq.gz
SAMN34331637	E177_15_10_2_1_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM IOX2 in position G10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_82_G10_ATTGGCTC_10_2_1_R1.fq.gz
SAMN34331638	E177_15_10_2_1_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZD2461 in position G11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_83_G11_CAAGGAGC_10_2_1_R1.fq.gz
SAMN34331267	E177_15_10_2_1_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_84_G12_CACCTTAC_10_2_1_R1.fq.gz
SAMN34331278	E177_15_10_2_1_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_85_H1_CCATCCTC_10_2_1_R1.fq.gz
SAMN34331639	E177_15_10_2_1_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ZM 447439 in position H02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_86_H2_CCGACAAC_10_2_1_R1.fq.gz
SAMN34331640	E177_15_10_2_1_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Barasertib (AZD1152-HQPA) in position H03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_87_H3_CCTAATCC_10_2_1_R1.fq.gz
SAMN34331641	E177_15_10_2_1_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 2-Methoxyestradiol (2-MeOE2) in position H04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_88_H4_CCTCTATC_10_2_1_R1.fq.gz
SAMN34331642	E177_15_10_2_1_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Pracinostat (SB939) in position H05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_89_H5_CGACACAC_10_2_1_R1.fq.gz
SAMN34331643	E177_15_10_2_1_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Givinostat (ITF2357) in position H06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_90_H6_CGGATTGC_10_2_1_R1.fq.gz
SAMN34331644	E177_15_10_2_1_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Quercetin in position H07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_91_H7_CTAAGGTC_10_2_1_R1.fq.gz
SAMN34331645	E177_15_10_2_1_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CCT137690 in position H08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_92_H8_GAACAGGC_10_2_1_R1.fq.gz
SAMN34331646	E177_15_10_2_1_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CEP-33779 in position H09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_93_H9_GACAGTGC_10_2_1_R1.fq.gz
SAMN34331647	E177_15_10_2_1_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Romidepsin (FK228, Depsipeptide) in position H10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_94_H10_GAGTTAGC_10_2_1_R1.fq.gz
SAMN34331648	E177_15_10_2_1_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM XL019 in position H11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_95_H11_GATGAATC_10_2_1_R1.fq.gz
SAMN34331278	E177_15_10_2_1_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_96_H12_GCCAAGAC_10_2_1_R1.fq.gz
SAMN34331245	E177_16_10_2_2_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_1_A1_ACAAGCTA_10_2_2_R1.fq.gz
SAMN34331649	E177_16_10_2_2_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Zebularine in position A02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_2_A2_AAACATCG_10_2_2_R1.fq.gz
SAMN34331650	E177_16_10_2_2_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM OG-L002 in position A03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_3_A3_ACATTGGC_10_2_2_R1.fq.gz
SAMN34331651	E177_16_10_2_2_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TMP269 in position A04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_4_A4_ACCACTGT_10_2_2_R1.fq.gz
SAMN34331652	E177_16_10_2_2_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ZM 39923 HCl in position A05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_5_A5_AACGTGAT_10_2_2_R1.fq.gz
SAMN34331653	E177_16_10_2_2_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Veliparib (ABT-888) in position A06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_6_A6_CGCTGATC_10_2_2_R1.fq.gz
SAMN34331654	E177_16_10_2_2_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CX-6258 HCl in position A07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_7_A7_CAGATCTG_10_2_2_R1.fq.gz
SAMN34331655	E177_16_10_2_2_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 2,4-Pyridinedicarboxylic Acid in position A08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_8_A8_ATGCCTAA_10_2_2_R1.fq.gz
SAMN34331656	E177_16_10_2_2_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ITSA-1 in position A09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_9_A9_CTGTAGCC_10_2_2_R1.fq.gz
SAMN34331657	E177_16_10_2_2_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AGK2 in position A10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_10_A10_AGTACAAG_10_2_2_R1.fq.gz
SAMN34331658	E177_16_10_2_2_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Oxamflatin in position A11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_11_A11_CATCAAGT_10_2_2_R1.fq.gz
SAMN34331245	E177_16_10_2_2_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_12_A12_AGTGGTCA_10_2_2_R1.fq.gz
SAMN34331256	E177_16_10_2_2_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_13_B1_AACAACCA_10_2_2_R1.fq.gz
SAMN34331659	E177_16_10_2_2_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 3-Deazaneplanocin A (DZNeP) in position B02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_14_B2_AACCGAGA_10_2_2_R1.fq.gz
SAMN34331660	E177_16_10_2_2_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGC-CBP30 in position B03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_15_B3_AACGCTTA_10_2_2_R1.fq.gz
SAMN34331661	E177_16_10_2_2_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EPZ004777 in position B04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_16_B4_AAGACGGA_10_2_2_R1.fq.gz
SAMN34331662	E177_16_10_2_2_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SMI-4a in position B05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_17_B5_AAGGTACA_10_2_2_R1.fq.gz
SAMN34331663	E177_16_10_2_2_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM FG-4592 in position B06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_18_B6_ACACAGAA_10_2_2_R1.fq.gz
SAMN34331664	E177_16_10_2_2_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BMN 673 in position B07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_19_B7_ACAGCAGA_10_2_2_R1.fq.gz
SAMN34331665	E177_16_10_2_2_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Garcinol in position B08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_20_B8_ACCTCCAA_10_2_2_R1.fq.gz
SAMN34331666	E177_16_10_2_2_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tranylcypromine hemisulfate in position B09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_21_B9_ACGCTCGA_10_2_2_R1.fq.gz
SAMN34331667	E177_16_10_2_2_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Salermide in position B10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_22_B10_ACGTATCA_10_2_2_R1.fq.gz
SAMN34331668	E177_16_10_2_2_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Suramin·6Na in position B11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_23_B11_ACTATGCA_10_2_2_R1.fq.gz
SAMN34331256	E177_16_10_2_2_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_24_B12_AGAGTCAA_10_2_2_R1.fq.gz
SAMN34331267	E177_16_10_2_2_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_25_C1_AGATCGCA_10_2_2_R1.fq.gz
SAMN34331669	E177_16_10_2_2_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EPZ-6438 in position C02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_26_C2_AGCAGGAA_10_2_2_R1.fq.gz
SAMN34331670	E177_16_10_2_2_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MM-102 in position C03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_27_C3_AGTCACTA_10_2_2_R1.fq.gz
SAMN34331671	E177_16_10_2_2_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM OTX015 in position C04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_28_C4_ATCCTGTA_10_2_2_R1.fq.gz
SAMN34331672	E177_16_10_2_2_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BIX 01294 in position C05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_29_C5_ATTGAGGA_10_2_2_R1.fq.gz
SAMN34331673	E177_16_10_2_2_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Panobinostat (LBH589) in position C06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_30_C6_CAACCACA_10_2_2_R1.fq.gz
SAMN34331674	E177_16_10_2_2_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EPZ5676 in position C07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_31_C7_CAAGACTA_10_2_2_R1.fq.gz
SAMN34331675	E177_16_10_2_2_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Splitomicin in position C08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_32_C8_CAATGGAA_10_2_2_R1.fq.gz
SAMN34331676	E177_16_10_2_2_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Valproic acid in position C09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_33_C9_CACTTCGA_10_2_2_R1.fq.gz
SAMN34331677	E177_16_10_2_2_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MC-1293 in position C10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_34_C10_CAGCGTTA_10_2_2_R1.fq.gz
SAMN34331678	E177_16_10_2_2_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-278 in position C11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_35_C11_CATACCAA_10_2_2_R1.fq.gz
SAMN34331267	E177_16_10_2_2_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_36_C12_CCAGTTCA_10_2_2_R1.fq.gz
SAMN34331278	E177_16_10_2_2_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_37_D1_CCGAAGTA_10_2_2_R1.fq.gz
SAMN34331679	E177_16_10_2_2_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM C646 in position D02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_38_D2_CCGTGAGA_10_2_2_R1.fq.gz
SAMN34331680	E177_16_10_2_2_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGI-1027 in position D03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_39_D3_CCTCCTGA_10_2_2_R1.fq.gz
SAMN34331681	E177_16_10_2_2_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM UNC669 in position D04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_40_D4_CGAACTTA_10_2_2_R1.fq.gz
SAMN34331682	E177_16_10_2_2_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM UPF 1069 in position D05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_41_D5_CGACTGGA_10_2_2_R1.fq.gz
SAMN34331683	E177_16_10_2_2_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Trichostatin A (TSA) in position D06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_42_D6_CGCATACA_10_2_2_R1.fq.gz
SAMN34331684	E177_16_10_2_2_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM GSK J4 HCl in position D07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_43_D7_CTCAATGA_10_2_2_R1.fq.gz
SAMN34331685	E177_16_10_2_2_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-210 in position D08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_44_D8_CTGAGCCA_10_2_2_R1.fq.gz
SAMN34331686	E177_16_10_2_2_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Nicotinamide in position D09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_45_D9_CTGGCATA_10_2_2_R1.fq.gz
SAMN34331687	E177_16_10_2_2_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Anacardic acid in position D10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_46_D10_GAATCTGA_10_2_2_R1.fq.gz
SAMN34331688	E177_16_10_2_2_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM NCH-51 in position D11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_47_D11_GACTAGTA_10_2_2_R1.fq.gz
SAMN34331278	E177_16_10_2_2_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_48_D12_GAGCTGAA_10_2_2_R1.fq.gz
SAMN34331245	E177_16_10_2_2_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_49_E1_GATAGACA_10_2_2_R1.fq.gz
SAMN34331689	E177_16_10_2_2_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM I-BET-762 in position E02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_50_E2_GCCACATA_10_2_2_R1.fq.gz
SAMN34331690	E177_16_10_2_2_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RG2833 (RGFP109) in position E03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_51_E3_GCGAGTAA_10_2_2_R1.fq.gz
SAMN34331691	E177_16_10_2_2_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ME0328 in position E04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_52_E4_GCTAACGA_10_2_2_R1.fq.gz
SAMN34331692	E177_16_10_2_2_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Scriptaid in position E05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_53_E5_GCTCGGTA_10_2_2_R1.fq.gz
SAMN34331693	E177_16_10_2_2_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Vorinostat (SAHA, MK0683) in position E06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_54_E6_GGAGAACA_10_2_2_R1.fq.gz
SAMN34331694	E177_16_10_2_2_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGC 0946 in position E07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_55_E7_GGTGCGAA_10_2_2_R1.fq.gz
SAMN34331695	E177_16_10_2_2_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Apicidin in position E08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_56_E8_GTACGCAA_10_2_2_R1.fq.gz
SAMN34331696	E177_16_10_2_2_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-266 in position E09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_57_E9_GTCGTAGA_10_2_2_R1.fq.gz
SAMN34331697	E177_16_10_2_2_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM B2 in position E10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_58_E10_GTCTGTCA_10_2_2_R1.fq.gz
SAMN34331698	E177_16_10_2_2_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM NSC-3852 in position E11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_59_E11_GTGTTCTA_10_2_2_R1.fq.gz
SAMN34331245	E177_16_10_2_2_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_60_E12_TAGGATGA_10_2_2_R1.fq.gz
SAMN34331256	E177_16_10_2_2_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_61_F1_TATCAGCA_10_2_2_R1.fq.gz
SAMN34331699	E177_16_10_2_2_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RGFP966 in position F02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_62_F2_TCCGTCTA_10_2_2_R1.fq.gz
SAMN34331700	E177_16_10_2_2_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RVX-208 in position F03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_63_F3_TCTTCACA_10_2_2_R1.fq.gz
SAMN34331701	E177_16_10_2_2_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Nexturastat A in position F04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_64_F4_TGAAGAGA_10_2_2_R1.fq.gz
SAMN34331702	E177_16_10_2_2_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tubastatin A in position F05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_65_F5_TGGAACAA_10_2_2_R1.fq.gz
SAMN34331703	E177_16_10_2_2_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM VX-680 (Tozasertib, MK-0457) in position F06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_66_F6_TGGCTTCA_10_2_2_R1.fq.gz
SAMN34331704	E177_16_10_2_2_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM UNC1215 in position F07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_67_F7_TGGTGGTA_10_2_2_R1.fq.gz
SAMN34331705	E177_16_10_2_2_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Suberoyl bis-hydroxamic acid in position F08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_68_F8_TTCACGCA_10_2_2_R1.fq.gz
SAMN34331706	E177_16_10_2_2_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Piceatannol in position F09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_69_F9_AACTCACC_10_2_2_R1.fq.gz
SAMN34331707	E177_16_10_2_2_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BIX-01294·3HCl in position F10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_70_F10_AAGAGATC_10_2_2_R1.fq.gz
SAMN34331708	E177_16_10_2_2_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Aminoresveratrol sulfate in position F11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_71_F11_AAGGACAC_10_2_2_R1.fq.gz
SAMN34331256	E177_16_10_2_2_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_72_F12_AATCCGTC_10_2_2_R1.fq.gz
SAMN34331267	E177_16_10_2_2_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_73_G1_AATGTTGC_10_2_2_R1.fq.gz
SAMN34331709	E177_16_10_2_2_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Bromosporine in position G02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_74_G2_ACACGACC_10_2_2_R1.fq.gz
SAMN34331710	E177_16_10_2_2_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PJ34 HCl in position G03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_75_G3_ACAGATTC_10_2_2_R1.fq.gz
SAMN34331711	E177_16_10_2_2_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Filgotinib (GLPG0634) in position G04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_76_G4_AGATGTAC_10_2_2_R1.fq.gz
SAMN34331712	E177_16_10_2_2_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Lomeguatrib in position G05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_77_G5_AGCACCTC_10_2_2_R1.fq.gz
SAMN34331713	E177_16_10_2_2_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Entinostat (MS-275) in position G06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_78_G6_AGCCATGC_10_2_2_R1.fq.gz
SAMN34331714	E177_16_10_2_2_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZD1208 in position G07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_79_G7_AGGCTAAC_10_2_2_R1.fq.gz
SAMN34331715	E177_16_10_2_2_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Nullscript in position G08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_80_G8_ATAGCGAC_10_2_2_R1.fq.gz
SAMN34331716	E177_16_10_2_2_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Fluoro-SAHA in position G09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_81_G9_ATCATTCC_10_2_2_R1.fq.gz
SAMN34331717	E177_16_10_2_2_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Butyrolactone 3 in position G10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_82_G10_ATTGGCTC_10_2_2_R1.fq.gz
SAMN34331718	E177_16_10_2_2_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-281 in position G11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_83_G11_CAAGGAGC_10_2_2_R1.fq.gz
SAMN34331267	E177_16_10_2_2_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_84_G12_CACCTTAC_10_2_2_R1.fq.gz
SAMN34331278	E177_16_10_2_2_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_85_H1_CCATCCTC_10_2_2_R1.fq.gz
SAMN34331719	E177_16_10_2_2_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM IOX1 in position H02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_86_H2_CCGACAAC_10_2_2_R1.fq.gz
SAMN34331720	E177_16_10_2_2_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CPI-203 in position H03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_87_H3_CCTAATCC_10_2_2_R1.fq.gz
SAMN34331721	E177_16_10_2_2_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Rocilinostat (ACY-1215) in position H04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_88_H4_CCTCTATC_10_2_2_R1.fq.gz
SAMN34331722	E177_16_10_2_2_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Pacritinib (SB1518) in position H05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_89_H5_CGACACAC_10_2_2_R1.fq.gz
SAMN34331723	E177_16_10_2_2_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Olaparib (AZD2281, Ku-0059436) in position H06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_90_H6_CGGATTGC_10_2_2_R1.fq.gz
SAMN34331724	E177_16_10_2_2_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM (+)-JQ1 in position H07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_91_H7_CTAAGGTC_10_2_2_R1.fq.gz
SAMN34331725	E177_16_10_2_2_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Isonicotinamide in position H08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_92_H8_GAACAGGC_10_2_2_R1.fq.gz
SAMN34331726	E177_16_10_2_2_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Valproic acid hydroxamate in position H09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_93_H9_GACAGTGC_10_2_2_R1.fq.gz
SAMN34331727	E177_16_10_2_2_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CTPB in position H10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_94_H10_GAGTTAGC_10_2_2_R1.fq.gz
SAMN34331728	E177_16_10_2_2_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Triacetylresveratrol in position H11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_95_H11_GATGAATC_10_2_2_R1.fq.gz
SAMN34331278	E177_16_10_2_2_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_96_H12_GCCAAGAC_10_2_2_R1.fq.gz
SAMN34331245	E177_17_10_3_1_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_1_A1_ACAAGCTA_10_3_1_R1.fq.gz
SAMN34331569	E177_17_10_3_1_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Belinostat (PXD101) in position A02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_2_A2_AAACATCG_10_3_1_R1.fq.gz
SAMN34331570	E177_17_10_3_1_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Danusertib (PHA-739358) in position A03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_3_A3_ACATTGGC_10_3_1_R1.fq.gz
SAMN34331571	E177_17_10_3_1_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SNS-314 Mesylate in position A04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_4_A4_ACCACTGT_10_3_1_R1.fq.gz
SAMN34331572	E177_17_10_3_1_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM JNJ-7706621 in position A05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_5_A5_AACGTGAT_10_3_1_R1.fq.gz
SAMN34331573	E177_17_10_3_1_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CCT129202 in position A06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_6_A6_CGCTGATC_10_3_1_R1.fq.gz
SAMN34331574	E177_17_10_3_1_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AG-14361 in position A07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_7_A7_CAGATCTG_10_3_1_R1.fq.gz
SAMN34331575	E177_17_10_3_1_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tubastatin A HCl in position A08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_8_A8_ATGCCTAA_10_3_1_R1.fq.gz
SAMN34331576	E177_17_10_3_1_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CUDC-907 in position A09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_9_A9_CTGTAGCC_10_3_1_R1.fq.gz
SAMN34331577	E177_17_10_3_1_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CI994 (Tacedinaline) in position A10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_10_A10_AGTACAAG_10_3_1_R1.fq.gz
SAMN34331578	E177_17_10_3_1_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Entacapone in position A11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_11_A11_CATCAAGT_10_3_1_R1.fq.gz
SAMN34331245	E177_17_10_3_1_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_12_A12_AGTGGTCA_10_3_1_R1.fq.gz
SAMN34331256	E177_17_10_3_1_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_13_B1_AACAACCA_10_3_1_R1.fq.gz
SAMN34331579	E177_17_10_3_1_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Iniparib (BSI-201) in position B02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_14_B2_AACCGAGA_10_3_1_R1.fq.gz
SAMN34331580	E177_17_10_3_1_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Mocetinostat (MGCD0103) in position B03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_15_B3_AACGCTTA_10_3_1_R1.fq.gz
SAMN34331581	E177_17_10_3_1_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Valproic acid sodium salt (Sodium valproate) in position B04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_16_B4_AAGACGGA_10_3_1_R1.fq.gz
SAMN34331582	E177_17_10_3_1_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Ruxolitinib (INCB018424) in position B05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_17_B5_AAGGTACA_10_3_1_R1.fq.gz
SAMN34331583	E177_17_10_3_1_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Hesperadin in position B06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_18_B6_ACACAGAA_10_3_1_R1.fq.gz
SAMN34331584	E177_17_10_3_1_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM LY2784544 in position B07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_19_B7_ACAGCAGA_10_3_1_R1.fq.gz
SAMN34331585	E177_17_10_3_1_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM NVP-BSK805 2HCl in position B08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_20_B8_ACCTCCAA_10_3_1_R1.fq.gz
SAMN34331586	E177_17_10_3_1_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MK-5108 (VX-689) in position B09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_21_B9_ACGCTCGA_10_3_1_R1.fq.gz
SAMN34331587	E177_17_10_3_1_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RG108 in position B10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_22_B10_ACGTATCA_10_3_1_R1.fq.gz
SAMN34331588	E177_17_10_3_1_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Sodium Phenylbutyrate in position B11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_23_B11_ACTATGCA_10_3_1_R1.fq.gz
SAMN34331256	E177_17_10_3_1_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_24_B12_AGAGTCAA_10_3_1_R1.fq.gz
SAMN34331267	E177_17_10_3_1_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_25_C1_AGATCGCA_10_3_1_R1.fq.gz
SAMN34331589	E177_17_10_3_1_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PCI-24781 (Abexinostat) in position C02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_26_C2_AGCAGGAA_10_3_1_R1.fq.gz
SAMN34331590	E177_17_10_3_1_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SRT1720 in position C03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_27_C3_AGTCACTA_10_3_1_R1.fq.gz
SAMN34331591	E177_17_10_3_1_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CYC116 in position C04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_28_C4_ATCCTGTA_10_3_1_R1.fq.gz
SAMN34331592	E177_17_10_3_1_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Resveratrol in position C05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_29_C5_ATTGAGGA_10_3_1_R1.fq.gz
SAMN34331593	E177_17_10_3_1_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EX 527 (Selisistat) in position C06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_30_C6_CAACCACA_10_3_1_R1.fq.gz
SAMN34331594	E177_17_10_3_1_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGI-1776 free base in position C07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_31_C7_CAAGACTA_10_3_1_R1.fq.gz
SAMN34331595	E177_17_10_3_1_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TG101209 in position C08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_32_C8_CAATGGAA_10_3_1_R1.fq.gz
SAMN34331596	E177_17_10_3_1_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM M344 in position C09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_33_C9_CACTTCGA_10_3_1_R1.fq.gz
SAMN34331597	E177_17_10_3_1_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Baricitinib (LY3009104, INCB028050) in position C10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_34_C10_CAGCGTTA_10_3_1_R1.fq.gz
SAMN34331598	E177_17_10_3_1_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tranylcypromine (2-PCPA) HCl in position C11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_35_C11_CATACCAA_10_3_1_R1.fq.gz
SAMN34331267	E177_17_10_3_1_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_36_C12_CCAGTTCA_10_3_1_R1.fq.gz
SAMN34331278	E177_17_10_3_1_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_37_D1_CCGAAGTA_10_3_1_R1.fq.gz
SAMN34331599	E177_17_10_3_1_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM LAQ824 (Dacinostat) in position D02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_38_D2_CCGTGAGA_10_3_1_R1.fq.gz
SAMN34331600	E177_17_10_3_1_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM INO-1001 in position D03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_39_D3_CCTCCTGA_10_3_1_R1.fq.gz
SAMN34331601	E177_17_10_3_1_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ENMD-2076 in position D04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_40_D4_CGAACTTA_10_3_1_R1.fq.gz
SAMN34331602	E177_17_10_3_1_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Droxinostat in position D05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_41_D5_CGACTGGA_10_3_1_R1.fq.gz
SAMN34331603	E177_17_10_3_1_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Azacitidine in position D06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_42_D6_CGCATACA_10_3_1_R1.fq.gz
SAMN34331604	E177_17_10_3_1_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZ 960 in position D07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_43_D7_CTCAATGA_10_3_1_R1.fq.gz
SAMN34331605	E177_17_10_3_1_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Resminostat in position D08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_44_D8_CTGAGCCA_10_3_1_R1.fq.gz
SAMN34331606	E177_17_10_3_1_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM I-BET151 (GSK1210151A) in position D09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_45_D9_CTGGCATA_10_3_1_R1.fq.gz
SAMN34331607	E177_17_10_3_1_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM WHI-P154 in position D10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_46_D10_GAATCTGA_10_3_1_R1.fq.gz
SAMN34331608	E177_17_10_3_1_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 3-Aminobenzamide in position D11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_47_D11_GACTAGTA_10_3_1_R1.fq.gz
SAMN34331278	E177_17_10_3_1_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_48_D12_GAGCTGAA_10_3_1_R1.fq.gz
SAMN34331245	E177_17_10_3_1_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_49_E1_GATAGACA_10_3_1_R1.fq.gz
SAMN34331609	E177_17_10_3_1_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Quisinostat (JNJ-26481585) in position E02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_50_E2_GCCACATA_10_3_1_R1.fq.gz
SAMN34331610	E177_17_10_3_1_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Alisertib (MLN8237) in position E03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_51_E3_GCGAGTAA_10_3_1_R1.fq.gz
SAMN34331611	E177_17_10_3_1_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CUDC-101 in position E04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_52_E4_GCTAACGA_10_3_1_R1.fq.gz
SAMN34331612	E177_17_10_3_1_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Aurora A Inhibitor I in position E05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_53_E5_GCTCGGTA_10_3_1_R1.fq.gz
SAMN34331613	E177_17_10_3_1_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PCI-34051 in position E06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_54_E6_GGAGAACA_10_3_1_R1.fq.gz
SAMN34331614	E177_17_10_3_1_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CYT387 in position E07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_55_E7_GGTGCGAA_10_3_1_R1.fq.gz
SAMN34331615	E177_17_10_3_1_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TAK-901 in position E08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_56_E8_GTACGCAA_10_3_1_R1.fq.gz
SAMN34331616	E177_17_10_3_1_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tofacitinib (CP-690550,Tasocitinib) in position E09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_57_E9_GTCGTAGA_10_3_1_R1.fq.gz
SAMN34331617	E177_17_10_3_1_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PJ34 in position E10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_58_E10_GTCTGTCA_10_3_1_R1.fq.gz
SAMN34331618	E177_17_10_3_1_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Procainamide HCl in position E11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_59_E11_GTGTTCTA_10_3_1_R1.fq.gz
SAMN34331245	E177_17_10_3_1_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_60_E12_TAGGATGA_10_3_1_R1.fq.gz
SAMN34331256	E177_17_10_3_1_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_61_F1_TATCAGCA_10_3_1_R1.fq.gz
SAMN34331619	E177_17_10_3_1_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Rucaparib (AG-014699,PF-01367338) in position F02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_62_F2_TCCGTCTA_10_3_1_R1.fq.gz
SAMN34331620	E177_17_10_3_1_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AT9283 in position F03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_63_F3_TCTTCACA_10_3_1_R1.fq.gz
SAMN34331621	E177_17_10_3_1_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Decitabine in position F04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_64_F4_TGAAGAGA_10_3_1_R1.fq.gz
SAMN34331622	E177_17_10_3_1_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PHA-680632 in position F05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_65_F5_TGGAACAA_10_3_1_R1.fq.gz
SAMN34331623	E177_17_10_3_1_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM KW-2449 in position F06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_66_F6_TGGCTTCA_10_3_1_R1.fq.gz
SAMN34331624	E177_17_10_3_1_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tubacin in position F07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_67_F7_TGGTGGTA_10_3_1_R1.fq.gz
SAMN34331625	E177_17_10_3_1_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AMG-900 in position F08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_68_F8_TTCACGCA_10_3_1_R1.fq.gz
SAMN34331626	E177_17_10_3_1_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM WP1066 in position F09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_69_F9_AACTCACC_10_3_1_R1.fq.gz
SAMN34331627	E177_17_10_3_1_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM S-Ruxolitinib (INCB018424) in position F10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_70_F10_AAGAGATC_10_3_1_R1.fq.gz
SAMN34331628	E177_17_10_3_1_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tofacitinib (CP-690550) Citrate in position F11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_71_F11_AAGGACAC_10_3_1_R1.fq.gz
SAMN34331256	E177_17_10_3_1_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_72_F12_AATCCGTC_10_3_1_R1.fq.gz
SAMN34331267	E177_17_10_3_1_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_73_G1_AATGTTGC_10_3_1_R1.fq.gz
SAMN34331629	E177_17_10_3_1_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MLN8054 in position G02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_74_G2_ACACGACC_10_3_1_R1.fq.gz
SAMN34331630	E177_17_10_3_1_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AG-490 (Tyrphostin B42) in position G03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_75_G3_ACAGATTC_10_3_1_R1.fq.gz
SAMN34331631	E177_17_10_3_1_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PFI-1 (PF-6405761) in position G04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_76_G4_AGATGTAC_10_3_1_R1.fq.gz
SAMN34331632	E177_17_10_3_1_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MC1568 in position G05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_77_G5_AGCACCTC_10_3_1_R1.fq.gz
SAMN34331633	E177_17_10_3_1_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZD1480 in position G06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_78_G6_AGCCATGC_10_3_1_R1.fq.gz
SAMN34331634	E177_17_10_3_1_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AR-42 in position G07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_79_G7_AGGCTAAC_10_3_1_R1.fq.gz
SAMN34331635	E177_17_10_3_1_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TG101348 (SAR302503) in position G08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_80_G8_ATAGCGAC_10_3_1_R1.fq.gz
SAMN34331636	E177_17_10_3_1_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Sirtinol in position G09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_81_G9_ATCATTCC_10_3_1_R1.fq.gz
SAMN34331637	E177_17_10_3_1_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM IOX2 in position G10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_82_G10_ATTGGCTC_10_3_1_R1.fq.gz
SAMN34331638	E177_17_10_3_1_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZD2461 in position G11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_83_G11_CAAGGAGC_10_3_1_R1.fq.gz
SAMN34331267	E177_17_10_3_1_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_84_G12_CACCTTAC_10_3_1_R1.fq.gz
SAMN34331278	E177_17_10_3_1_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_85_H1_CCATCCTC_10_3_1_R1.fq.gz
SAMN34331639	E177_17_10_3_1_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ZM 447439 in position H02 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_86_H2_CCGACAAC_10_3_1_R1.fq.gz
SAMN34331640	E177_17_10_3_1_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Barasertib (AZD1152-HQPA) in position H03 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_87_H3_CCTAATCC_10_3_1_R1.fq.gz
SAMN34331641	E177_17_10_3_1_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 2-Methoxyestradiol (2-MeOE2) in position H04 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_88_H4_CCTCTATC_10_3_1_R1.fq.gz
SAMN34331642	E177_17_10_3_1_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Pracinostat (SB939) in position H05 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_89_H5_CGACACAC_10_3_1_R1.fq.gz
SAMN34331643	E177_17_10_3_1_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Givinostat (ITF2357) in position H06 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_90_H6_CGGATTGC_10_3_1_R1.fq.gz
SAMN34331644	E177_17_10_3_1_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Quercetin in position H07 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_91_H7_CTAAGGTC_10_3_1_R1.fq.gz
SAMN34331645	E177_17_10_3_1_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CCT137690 in position H08 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_92_H8_GAACAGGC_10_3_1_R1.fq.gz
SAMN34331646	E177_17_10_3_1_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CEP-33779 in position H09 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_93_H9_GACAGTGC_10_3_1_R1.fq.gz
SAMN34331647	E177_17_10_3_1_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Romidepsin (FK228, Depsipeptide) in position H10 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_94_H10_GAGTTAGC_10_3_1_R1.fq.gz
SAMN34331648	E177_17_10_3_1_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM XL019 in position H11 in plate 1	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_95_H11_GATGAATC_10_3_1_R1.fq.gz
SAMN34331278	E177_17_10_3_1_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_96_H12_GCCAAGAC_10_3_1_R1.fq.gz
SAMN34331245	E177_18_10_3_2_A01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_1_A1_ACAAGCTA_10_3_2_R1.fq.gz
SAMN34331649	E177_18_10_3_2_A02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Zebularine in position A02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_2_A2_AAACATCG_10_3_2_R1.fq.gz
SAMN34331650	E177_18_10_3_2_A03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM OG-L002 in position A03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_3_A3_ACATTGGC_10_3_2_R1.fq.gz
SAMN34331651	E177_18_10_3_2_A04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM TMP269 in position A04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_4_A4_ACCACTGT_10_3_2_R1.fq.gz
SAMN34331652	E177_18_10_3_2_A05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ZM 39923 HCl in position A05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_5_A5_AACGTGAT_10_3_2_R1.fq.gz
SAMN34331653	E177_18_10_3_2_A06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Veliparib (ABT-888) in position A06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_6_A6_CGCTGATC_10_3_2_R1.fq.gz
SAMN34331654	E177_18_10_3_2_A07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CX-6258 HCl in position A07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_7_A7_CAGATCTG_10_3_2_R1.fq.gz
SAMN34331655	E177_18_10_3_2_A08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 2,4-Pyridinedicarboxylic Acid in position A08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_8_A8_ATGCCTAA_10_3_2_R1.fq.gz
SAMN34331656	E177_18_10_3_2_A09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ITSA-1 in position A09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_9_A9_CTGTAGCC_10_3_2_R1.fq.gz
SAMN34331657	E177_18_10_3_2_A10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AGK2 in position A10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_10_A10_AGTACAAG_10_3_2_R1.fq.gz
SAMN34331658	E177_18_10_3_2_A11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Oxamflatin in position A11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_11_A11_CATCAAGT_10_3_2_R1.fq.gz
SAMN34331245	E177_18_10_3_2_A12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_12_A12_AGTGGTCA_10_3_2_R1.fq.gz
SAMN34331256	E177_18_10_3_2_B01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_13_B1_AACAACCA_10_3_2_R1.fq.gz
SAMN34331659	E177_18_10_3_2_B02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM 3-Deazaneplanocin A (DZNeP) in position B02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_14_B2_AACCGAGA_10_3_2_R1.fq.gz
SAMN34331660	E177_18_10_3_2_B03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGC-CBP30 in position B03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_15_B3_AACGCTTA_10_3_2_R1.fq.gz
SAMN34331661	E177_18_10_3_2_B04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EPZ004777 in position B04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_16_B4_AAGACGGA_10_3_2_R1.fq.gz
SAMN34331662	E177_18_10_3_2_B05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SMI-4a in position B05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_17_B5_AAGGTACA_10_3_2_R1.fq.gz
SAMN34331663	E177_18_10_3_2_B06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM FG-4592 in position B06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_18_B6_ACACAGAA_10_3_2_R1.fq.gz
SAMN34331664	E177_18_10_3_2_B07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BMN 673 in position B07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_19_B7_ACAGCAGA_10_3_2_R1.fq.gz
SAMN34331665	E177_18_10_3_2_B08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Garcinol in position B08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_20_B8_ACCTCCAA_10_3_2_R1.fq.gz
SAMN34331666	E177_18_10_3_2_B09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tranylcypromine hemisulfate in position B09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_21_B9_ACGCTCGA_10_3_2_R1.fq.gz
SAMN34331667	E177_18_10_3_2_B10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Salermide in position B10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_22_B10_ACGTATCA_10_3_2_R1.fq.gz
SAMN34331668	E177_18_10_3_2_B11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Suramin·6Na in position B11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_23_B11_ACTATGCA_10_3_2_R1.fq.gz
SAMN34331256	E177_18_10_3_2_B12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_24_B12_AGAGTCAA_10_3_2_R1.fq.gz
SAMN34331267	E177_18_10_3_2_C01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_25_C1_AGATCGCA_10_3_2_R1.fq.gz
SAMN34331669	E177_18_10_3_2_C02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EPZ-6438 in position C02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_26_C2_AGCAGGAA_10_3_2_R1.fq.gz
SAMN34331670	E177_18_10_3_2_C03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MM-102 in position C03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_27_C3_AGTCACTA_10_3_2_R1.fq.gz
SAMN34331671	E177_18_10_3_2_C04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM OTX015 in position C04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_28_C4_ATCCTGTA_10_3_2_R1.fq.gz
SAMN34331672	E177_18_10_3_2_C05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BIX 01294 in position C05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_29_C5_ATTGAGGA_10_3_2_R1.fq.gz
SAMN34331673	E177_18_10_3_2_C06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Panobinostat (LBH589) in position C06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_30_C6_CAACCACA_10_3_2_R1.fq.gz
SAMN34331674	E177_18_10_3_2_C07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM EPZ5676 in position C07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_31_C7_CAAGACTA_10_3_2_R1.fq.gz
SAMN34331675	E177_18_10_3_2_C08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Splitomicin in position C08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_32_C8_CAATGGAA_10_3_2_R1.fq.gz
SAMN34331676	E177_18_10_3_2_C09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Valproic acid in position C09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_33_C9_CACTTCGA_10_3_2_R1.fq.gz
SAMN34331677	E177_18_10_3_2_C10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM MC-1293 in position C10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_34_C10_CAGCGTTA_10_3_2_R1.fq.gz
SAMN34331678	E177_18_10_3_2_C11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-278 in position C11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_35_C11_CATACCAA_10_3_2_R1.fq.gz
SAMN34331267	E177_18_10_3_2_C12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_36_C12_CCAGTTCA_10_3_2_R1.fq.gz
SAMN34331278	E177_18_10_3_2_D01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_37_D1_CCGAAGTA_10_3_2_R1.fq.gz
SAMN34331679	E177_18_10_3_2_D02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM C646 in position D02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_38_D2_CCGTGAGA_10_3_2_R1.fq.gz
SAMN34331680	E177_18_10_3_2_D03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGI-1027 in position D03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_39_D3_CCTCCTGA_10_3_2_R1.fq.gz
SAMN34331681	E177_18_10_3_2_D04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM UNC669 in position D04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_40_D4_CGAACTTA_10_3_2_R1.fq.gz
SAMN34331682	E177_18_10_3_2_D05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM UPF 1069 in position D05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_41_D5_CGACTGGA_10_3_2_R1.fq.gz
SAMN34331683	E177_18_10_3_2_D06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Trichostatin A (TSA) in position D06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_42_D6_CGCATACA_10_3_2_R1.fq.gz
SAMN34331684	E177_18_10_3_2_D07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM GSK J4 HCl in position D07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_43_D7_CTCAATGA_10_3_2_R1.fq.gz
SAMN34331685	E177_18_10_3_2_D08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-210 in position D08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_44_D8_CTGAGCCA_10_3_2_R1.fq.gz
SAMN34331686	E177_18_10_3_2_D09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Nicotinamide in position D09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_45_D9_CTGGCATA_10_3_2_R1.fq.gz
SAMN34331687	E177_18_10_3_2_D10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Anacardic acid in position D10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_46_D10_GAATCTGA_10_3_2_R1.fq.gz
SAMN34331688	E177_18_10_3_2_D11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM NCH-51 in position D11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_47_D11_GACTAGTA_10_3_2_R1.fq.gz
SAMN34331278	E177_18_10_3_2_D12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_48_D12_GAGCTGAA_10_3_2_R1.fq.gz
SAMN34331245	E177_18_10_3_2_E01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_49_E1_GATAGACA_10_3_2_R1.fq.gz
SAMN34331689	E177_18_10_3_2_E02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM I-BET-762 in position E02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_50_E2_GCCACATA_10_3_2_R1.fq.gz
SAMN34331690	E177_18_10_3_2_E03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RG2833 (RGFP109) in position E03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_51_E3_GCGAGTAA_10_3_2_R1.fq.gz
SAMN34331691	E177_18_10_3_2_E04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM ME0328 in position E04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_52_E4_GCTAACGA_10_3_2_R1.fq.gz
SAMN34331692	E177_18_10_3_2_E05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Scriptaid in position E05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_53_E5_GCTCGGTA_10_3_2_R1.fq.gz
SAMN34331693	E177_18_10_3_2_E06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Vorinostat (SAHA, MK0683) in position E06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_54_E6_GGAGAACA_10_3_2_R1.fq.gz
SAMN34331694	E177_18_10_3_2_E07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM SGC 0946 in position E07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_55_E7_GGTGCGAA_10_3_2_R1.fq.gz
SAMN34331695	E177_18_10_3_2_E08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Apicidin in position E08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_56_E8_GTACGCAA_10_3_2_R1.fq.gz
SAMN34331696	E177_18_10_3_2_E09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-266 in position E09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_57_E9_GTCGTAGA_10_3_2_R1.fq.gz
SAMN34331697	E177_18_10_3_2_E10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM B2 in position E10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_58_E10_GTCTGTCA_10_3_2_R1.fq.gz
SAMN34331698	E177_18_10_3_2_E11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM NSC-3852 in position E11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_59_E11_GTGTTCTA_10_3_2_R1.fq.gz
SAMN34331245	E177_18_10_3_2_E12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_60_E12_TAGGATGA_10_3_2_R1.fq.gz
SAMN34331256	E177_18_10_3_2_F01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_61_F1_TATCAGCA_10_3_2_R1.fq.gz
SAMN34331699	E177_18_10_3_2_F02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RGFP966 in position F02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_62_F2_TCCGTCTA_10_3_2_R1.fq.gz
SAMN34331700	E177_18_10_3_2_F03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM RVX-208 in position F03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_63_F3_TCTTCACA_10_3_2_R1.fq.gz
SAMN34331701	E177_18_10_3_2_F04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Nexturastat A in position F04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_64_F4_TGAAGAGA_10_3_2_R1.fq.gz
SAMN34331702	E177_18_10_3_2_F05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Tubastatin A in position F05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_65_F5_TGGAACAA_10_3_2_R1.fq.gz
SAMN34331703	E177_18_10_3_2_F06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM VX-680 (Tozasertib, MK-0457) in position F06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_66_F6_TGGCTTCA_10_3_2_R1.fq.gz
SAMN34331704	E177_18_10_3_2_F07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM UNC1215 in position F07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_67_F7_TGGTGGTA_10_3_2_R1.fq.gz
SAMN34331705	E177_18_10_3_2_F08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Suberoyl bis-hydroxamic acid in position F08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_68_F8_TTCACGCA_10_3_2_R1.fq.gz
SAMN34331706	E177_18_10_3_2_F09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Piceatannol in position F09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_69_F9_AACTCACC_10_3_2_R1.fq.gz
SAMN34331707	E177_18_10_3_2_F10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BIX-01294·3HCl in position F10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_70_F10_AAGAGATC_10_3_2_R1.fq.gz
SAMN34331708	E177_18_10_3_2_F11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Aminoresveratrol sulfate in position F11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_71_F11_AAGGACAC_10_3_2_R1.fq.gz
SAMN34331256	E177_18_10_3_2_F12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_72_F12_AATCCGTC_10_3_2_R1.fq.gz
SAMN34331267	E177_18_10_3_2_G01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_73_G1_AATGTTGC_10_3_2_R1.fq.gz
SAMN34331709	E177_18_10_3_2_G02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Bromosporine in position G02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_74_G2_ACACGACC_10_3_2_R1.fq.gz
SAMN34331710	E177_18_10_3_2_G03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM PJ34 HCl in position G03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_75_G3_ACAGATTC_10_3_2_R1.fq.gz
SAMN34331711	E177_18_10_3_2_G04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Filgotinib (GLPG0634) in position G04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_76_G4_AGATGTAC_10_3_2_R1.fq.gz
SAMN34331712	E177_18_10_3_2_G05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Lomeguatrib in position G05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_77_G5_AGCACCTC_10_3_2_R1.fq.gz
SAMN34331713	E177_18_10_3_2_G06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Entinostat (MS-275) in position G06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_78_G6_AGCCATGC_10_3_2_R1.fq.gz
SAMN34331714	E177_18_10_3_2_G07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM AZD1208 in position G07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_79_G7_AGGCTAAC_10_3_2_R1.fq.gz
SAMN34331715	E177_18_10_3_2_G08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Nullscript in position G08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_80_G8_ATAGCGAC_10_3_2_R1.fq.gz
SAMN34331716	E177_18_10_3_2_G09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Fluoro-SAHA in position G09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_81_G9_ATCATTCC_10_3_2_R1.fq.gz
SAMN34331717	E177_18_10_3_2_G10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Butyrolactone 3 in position G10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_82_G10_ATTGGCTC_10_3_2_R1.fq.gz
SAMN34331718	E177_18_10_3_2_G11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM BML-281 in position G11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_83_G11_CAAGGAGC_10_3_2_R1.fq.gz
SAMN34331267	E177_18_10_3_2_G12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_84_G12_CACCTTAC_10_3_2_R1.fq.gz
SAMN34331278	E177_18_10_3_2_H01	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_85_H1_CCATCCTC_10_3_2_R1.fq.gz
SAMN34331719	E177_18_10_3_2_H02	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM IOX1 in position H02 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_86_H2_CCGACAAC_10_3_2_R1.fq.gz
SAMN34331720	E177_18_10_3_2_H03	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CPI-203 in position H03 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_87_H3_CCTAATCC_10_3_2_R1.fq.gz
SAMN34331721	E177_18_10_3_2_H04	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Rocilinostat (ACY-1215) in position H04 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_88_H4_CCTCTATC_10_3_2_R1.fq.gz
SAMN34331722	E177_18_10_3_2_H05	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Pacritinib (SB1518) in position H05 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_89_H5_CGACACAC_10_3_2_R1.fq.gz
SAMN34331723	E177_18_10_3_2_H06	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Olaparib (AZD2281, Ku-0059436) in position H06 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_90_H6_CGGATTGC_10_3_2_R1.fq.gz
SAMN34331724	E177_18_10_3_2_H07	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM (+)-JQ1 in position H07 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_91_H7_CTAAGGTC_10_3_2_R1.fq.gz
SAMN34331725	E177_18_10_3_2_H08	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Isonicotinamide in position H08 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_92_H8_GAACAGGC_10_3_2_R1.fq.gz
SAMN34331726	E177_18_10_3_2_H09	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Valproic acid hydroxamate in position H09 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_93_H9_GACAGTGC_10_3_2_R1.fq.gz
SAMN34331727	E177_18_10_3_2_H10	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM CTPB in position H10 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_94_H10_GAGTTAGC_10_3_2_R1.fq.gz
SAMN34331728	E177_18_10_3_2_H11	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 10 µM Triacetylresveratrol in position H11 in plate 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_95_H11_GATGAATC_10_3_2_R1.fq.gz
SAMN34331278	E177_18_10_3_2_H12	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2	AMPLICON	GENOMIC	PCR	single	ILLUMINA	Illumina MiSeq	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP clone #5, 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	5280_96_H12_GCCAAGAC_10_3_2_R1.fq.gz
SAMN34331729	HDACi_rep1_E1650_A_RSTP2_pools_LBR2_DMSO_-_72_run1	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen in position treated with  DMSO	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP pools treated with Vorinostat or DMSO (equal volume), 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6543_3_HDACi_rep1_E1650_A_RSTP2_LBR2_DMSO_AACGCTTA_S4_R1_001.fastq.gz
SAMN34331730	HDACi_rep1_E1650_A_RSTP2_pools_LBR2_Vorinostat_-_72_run1	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen in position treated with  Vorinostat	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP pools treated with Vorinostat or DMSO (equal volume), 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6543_4_HDACi_rep1_E1650_A_RSTP2_LBR2_Vorinostat_AAGACGGA_S8_R1_001.fastq.gz
SAMN34331729	HDACi_rep1_E1650_B_RSTP2_pools_LBR2_DMSO_-_72_run1	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen in position treated with  DMSO	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP pools treated with Vorinostat or DMSO (equal volume), 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6543_7_HDACi_rep1_E1650_B_RSTP2_LBR2_DMSO_ACAGCAGA_S12_R1_001.fastq.gz
SAMN34331730	HDACi_rep1_E1650_B_RSTP2_pools_LBR2_Vorinostat_-_72_run1	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen in position treated with  Vorinostat	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP pools treated with Vorinostat or DMSO (equal volume), 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6543_8_HDACi_rep1_E1650_B_RSTP2_LBR2_Vorinostat_ACCTCCAA_S14_R1_001.fastq.gz
SAMN34331729	HDACi_rep2_E1650_A_RSTP2_pools_LBR2_DMSO_-_72_run1	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen in position treated with  DMSO	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP pools treated with Vorinostat or DMSO (equal volume), 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6543_11_HDACi_rep2_E1650_A_RSTP2_LBR2_DMSO_ACTATGCA_S18_R1_001.fastq.gz
SAMN34331730	HDACi_rep2_E1650_A_RSTP2_pools_LBR2_Vorinostat_-_72_run1	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen in position treated with  Vorinostat	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP pools treated with Vorinostat or DMSO (equal volume), 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6543_12_HDACi_rep2_E1650_A_RSTP2_LBR2_Vorinostat_AGAGTCAA_S17_R1_001.fastq.gz
SAMN34331729	HDACi_rep2_E1650_B_RSTP2_pools_LBR2_DMSO_-_72_run1	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen in position treated with  DMSO	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP pools treated with Vorinostat or DMSO (equal volume), 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6543_15_HDACi_rep2_E1650_B_RSTP2_LBR2_DMSO_AGTCACTA_S16_R1_001.fastq.gz
SAMN34331730	HDACi_rep2_E1650_B_RSTP2_pools_LBR2_Vorinostat_-_72_run1	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen in position treated with  Vorinostat	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP pools treated with Vorinostat or DMSO (equal volume), 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6543_16_HDACi_rep2_E1650_B_RSTP2_LBR2_Vorinostat_ATCCTGTA_S6_R1_001.fastq.gz
SAMN34331729	HDACi_rep3_E1650_A_RSTP2_pools_LBR2_DMSO_-_72_run1	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen in position treated with  DMSO	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP pools treated with Vorinostat or DMSO (equal volume), 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6543_19_HDACi_rep3_E1650_A_RSTP2_LBR2_DMSO_CAAGACTA_S20_R1_001.fastq.gz
SAMN34331730	HDACi_rep3_E1650_A_RSTP2_pools_LBR2_Vorinostat_-_72_run1	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen in position treated with  Vorinostat	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP pools treated with Vorinostat or DMSO (equal volume), 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6543_20_HDACi_rep3_E1650_A_RSTP2_LBR2_Vorinostat_CAATGGAA_S15_R1_001.fastq.gz
SAMN34331729	HDACi_rep3_E1650_B_RSTP2_pools_LBR2_DMSO_-_72_run1	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen in position treated with  DMSO	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP pools treated with Vorinostat or DMSO (equal volume), 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6543_23_HDACi_rep3_E1650_B_RSTP2_LBR2_DMSO_CATACCAA_S23_R1_001.fastq.gz
SAMN34331730	HDACi_rep3_E1650_B_RSTP2_pools_LBR2_Vorinostat_-_72_run1	CRISPR/Cas9 mutation readout on the pathway reporters in Sample from drug screen in position treated with  Vorinostat	AMPLICON	GENOMIC	PCR	single	ILLUMINA	NextSeq 500	CRISPR/Cas9 mutation readout on the pathway reporters in different K562 TRIP pools treated with Vorinostat or DMSO (equal volume), 72 hours after activation the cells were collected and processed with two successive PCRs on the integrated pathway reporters to generate the libraries, spanning the sgRNA target site and the barcode	fastq	6543_24_HDACi_rep3_E1650_B_RSTP2_LBR2_Vorinostat_CCAGTTCA_S24_R1_001.fastq.gz
